Blue Jet Healthcare Limited has announced its unaudited standalone financial results for the quarter and half-year ended September 30, 2026. The Board of Directors approved these results on November 5, 2026. The company’s total income for the quarter reached ₹4,019.52 million, with profit after tax standing at ₹1,025.17 million. For the six-month period, total income was ₹7,103.01 million, and profit after tax was ₹1,807.81 million.
Blue Jet Healthcare Announces Financial Results for Q2 and H1 FY27
Blue Jet Healthcare Limited has officially declared its unaudited standalone financial results for the second quarter (Q2) and the first half-year (H1) ended September 30, 2026. The approval of these results by the Board of Directors took place during a meeting held on November 5, 2026.
Quarterly Performance (Q2 FY27)
For the three months ended September 30, 2026, Blue Jet Healthcare reported a total income of ₹4,019.52 million. This figure is an aggregation of Revenue from Operations amounting to ₹3,757.44 million and Other Income of ₹262.08 million. Total expenses for the quarter were ₹2,645.58 million. The company’s Profit Before Tax for the quarter stood at ₹1,373.94 million. After accounting for a Tax Expense of ₹348.77 million, the Profit After Tax for the quarter was ₹1,025.17 million.
Half-Yearly Performance (H1 FY27)
The six-month period ended September 30, 2026, saw Blue Jet Healthcare achieve a total income of ₹7,103.01 million. This comprises Revenue from Operations of ₹6,688.57 million and Other Income of ₹414.44 million. Total expenses for the period amounted to ₹4,669.61 million. Profit Before Tax for the half-year was ₹2,433.40 million. The Tax Expense was ₹625.59 million, resulting in a Profit After Tax of ₹1,807.81 million for the six months.
Key Financial Highlights
Earnings per share (EPS) for the quarter (Basic and Diluted) were reported at ₹5.46. For the half-year, EPS (Basic and Diluted) stood at ₹10.00. The company also disclosed its Statement of Assets and Liabilities as at September 30, 2026, showing Total Assets of ₹25,838.78 million and Total Equity and Liabilities of ₹25,838.78 million. A Statement of Cash Flows for the six-month periods ended September 30, 2026, and September 30, 2025, was also provided.
The financial results have been reviewed by the Audit Committee and approved by the Board of Directors. Furthermore, the results have undergone a review by the Statutory Auditor of the Company.
Source: BSE
